Theralink Technologies Inc (THER)

[Mprush]

I'm thinking we'll continue to hover
around the .10-.18 zone until significant news hits. While I understand this stock is relatively unknown to the majority of investors, the market has made it pretty clear that we absolutely need better financing if we want to move forward with our plan. Hopefully the Vitel acquisition details benefit us in that respect. The latest PR update states a US Phase 2 in "early 2017", which is about a year later than originally anticipated when the company went public. Dr Head will need to prove to investors that he's serious about the direction of OMBP if we want big pharma to take us seriously.